Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Integrative medicine: complementary therapies and supplements

Nature Reviews Urology volume 6, pages 228–233 (2009)Cite this article

A Correction to this article was published on 01 July 2009

Abstract

Many patients with cancer or other urologic disorders use complementary therapies in an effort to control symptoms and to prevent and treat disease. Complementary modalities are adjuncts to mainstream treatment. These safe, evidence-based therapies reduce symptoms associated with treatment of urologic cancers and other illnesses. They are to be distinguished from 'alternative therapies', which are unproven, potentially harmful, and often promoted as substitutes for mainstream medical care. Accumulating evidence supports the beneficial impact of complementary therapies, such as acupuncture, yoga, meditation and physical activity, on physical and emotional symptoms associated with cancer treatment, for which there are few effective standard interventions. Herbs and other dietary supplements are unlikely to be beneficial, and might be problematic or dangerous when taken during cancer treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lippert, M. C. et al. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer 86, 2642–2648 (1999).

    Article  CAS  Google Scholar 

  2. Dreikorn, K. Complementary and alternative medicine in urology. BJU Int. 96, 1177–1184 (2005).

    Article  CAS  Google Scholar 

  3. Rackley, J. D. et al. Complementary and alternative medicine for advanced prostate cancer. Urol. Clin. North Am. 33, 237–246 (2006).

    Article  Google Scholar 

  4. Society of Integrative Oncology. http://www.integrativeonc.org (2009).

  5. Wilkinson, S. et al. Attitudes and use of complementary medicine in men with prostate cancer. J. Urol. 168, 2505–2509 (2002).

    Article  Google Scholar 

  6. Hall, J. D. et al. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int. 91, 603–607 (2003).

    Article  CAS  Google Scholar 

  7. Listing, M. et al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer. Psychooncology doi:10.1002/pon.1508 (2009).

  8. Cassileth, B. R. & Vickers, A. J. Massage therapy for symptom control: outcome study at a major cancer center. J. Pain Symptom Manage. 28, 244–9 (2004).

    Article  Google Scholar 

  9. Pomeranz, B. & Warma, N. Electroacupuncture suppression of a nociceptive reflex is potentiated by two repeated electroacupuncture treatments: the first opioid effect potentiates a second non-opioid effect. Brain Res. 452, 232–236 (1988).

    Article  CAS  Google Scholar 

  10. Yoo, S. S. et al. Modulation of cerebellar activities by acupuncture stimulation: evidence from fMRI study. Neuroimage 22, 932–940 (2004).

    Article  Google Scholar 

  11. Honjo, H. et al. Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. Int. J. Urol. 11, 607–612 (2004).

    Article  Google Scholar 

  12. Ee, C. C. et al. Acupuncture for pelvic and back pain in pregnancy: a systematic review. Am. J. Obstet. Gynecol. 198, 254–259 (2008).

    Article  Google Scholar 

  13. Baum, N. H. & Torti, D. C. Managing hot flashes in men being treated for prostate cancer. Geriatrics 62, 18–21 (2007).

    PubMed  Google Scholar 

  14. Guise, T. A. et al. Estrogenic side effects of androgen deprivation therapy. Rev. Urol. 9, 163–180 (2007).

    PubMed  PubMed Central  Google Scholar 

  15. Filshie, J. et al. Acupuncture and self acupuncture for long-term treatment of vasomotor symptoms in cancer patients—audit and treatment algorithm. Acupunct. Med. 23, 171–180 (2005).

    Article  Google Scholar 

  16. Hammar, M. et al. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J. Urol. 161, 853–856 (1999).

    Article  CAS  Google Scholar 

  17. Kingston, J. et al. A pilot randomized control trial investigating the effect of mindfulness practice on pain tolerance, psychological well-being, and physiological activity. J. Psychosom. Res. 62, 297–300 (2007).

    Article  Google Scholar 

  18. Morone, N. E. et al. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. Pain 134, 310–319 (2008).

    Article  Google Scholar 

  19. Paul-Labrador, M. et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch. Intern. Med. 166, 1218–1224 (2006).

    Article  Google Scholar 

  20. Curiati, J. A. et al. Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J. Altern. Complement. Med. 11, 465–472 (2005).

    Article  Google Scholar 

  21. Koszycki, D. et al. Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder. Behav. Res. Ther. 45, 2518–2526 (2007).

    Article  Google Scholar 

  22. Lee, S. H. et al. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J. Psychosom. Res. 62, 189–195 (2007).

    Article  Google Scholar 

  23. Watanabe, E. et al. Effects among healthy subjects of the duration of regularly practicing a guided imagery program. BMC Complement. Altern. Med. 5, 21 (2005).

    Article  Google Scholar 

  24. Mannix, L. K. et al. Effect of guided imagery on quality of life for patients with chronic tension-type headache. Headache 39, 326–334 (1999).

    Article  CAS  Google Scholar 

  25. Holmes, E. A. et al. Positive interpretation training: effects of mental imagery versus verbal training on positive mood. Behav. Ther. 37, 237–247 (2006).

    Article  Google Scholar 

  26. Carlson, L. E. et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinol. 29, 448–474 (2004).

    Article  CAS  Google Scholar 

  27. Carlson, L. E. et al. One year pre–post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav. Immun. 21, 1038–1049 (2007).

    Article  CAS  Google Scholar 

  28. Hill, J. R. et al. Patient perceived outcomes of treatments used for interstitial cystitis. Urology 71, 62–66 (2008).

    Article  Google Scholar 

  29. Forrest, J. B. et al. Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. Urology 69, 60–63 (2007).

    Article  Google Scholar 

  30. Carrico, D. J. et al. Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J. Altern. Complement. Med. 14, 53–60 (2008).

    Article  Google Scholar 

  31. Ripoll, E. & Mahowald, D. Hatha Yoga therapy management of urologic disorders. World J. Urol. 20, 306–309 (2002).

    PubMed  Google Scholar 

  32. Smith, M. et al. Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Oncol. Nurs. Forum 28, 855–862 (2001).

    CAS  PubMed  Google Scholar 

  33. Yung, P. M. et al. A controlled trial of music and pre-operative anxiety in Chinese men undergoing transurethral resection of the prostate. J. Adv. Nurs. 39, 352–359 (2002).

    Article  Google Scholar 

  34. Ciancarelli, I. et al. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 27, 1136–1141 (2007).

    Article  CAS  Google Scholar 

  35. Tsai, P. S. et al. Blood pressure biofeedback exerts intermediate-term effects on blood pressure and pressure reactivity in individuals with mild hypertension: a randomized controlled study. J. Altern. Complement. Med. 13, 547–554 (2007).

    Article  Google Scholar 

  36. Tsai, P. S. et al. Effects of electromyography biofeedback-assisted relaxation on pain in patients with advanced cancer in a palliative care unit. Cancer Nurs. 30, 347–353 (2007).

    Article  Google Scholar 

  37. Burgio, K. L. et al. Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial. J. Urol. 175, 196–201 (2006).

    Article  Google Scholar 

  38. Kibar, Y. et al. Effect of biofeedback treatment on spinning top urethra in children with voiding dysfunction. Urology 70, 781–784 (2007).

    Article  Google Scholar 

  39. Demark-Wahnefried, W. et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J. Clin. Oncol. 25, 2709–2718 (2007).

    Article  Google Scholar 

  40. Truong, P. T. et al. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can. J. Urol. 13, 3139–3146 (2006).

    PubMed  Google Scholar 

  41. Windsor, P. M. et al. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101, 550–557 (2004).

    Article  Google Scholar 

  42. Giubilei, G. et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments—could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. J. Urol. 177, 159–165 (2007).

    Article  Google Scholar 

  43. Litwin, M. S. et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273, 129–135 (1995).

    Article  CAS  Google Scholar 

  44. Madalinska, J. B. et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J. Clin. Oncol. 19, 1619–1628 (2001).

    Article  CAS  Google Scholar 

  45. Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1261 (2008).

    Article  CAS  Google Scholar 

  46. Daly, M. P. Quality of life in sexually active men with symptomatic benign prostatic hyperplasia: effects of treatment. Clin. Drug Investig. 25, 219–230 (2005).

    Article  Google Scholar 

  47. Dorey, G. et al. Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction. Br. J. Gen. Pract. 54, 819–825 (2004).

    PubMed  PubMed Central  Google Scholar 

  48. Dahn, J. R. et al. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology 65, 953–958 (2005).

    Article  Google Scholar 

  49. Parsons, J. K. & Kashefi, C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur. Urol. 53, 1228–1235 (2008).

    Article  Google Scholar 

  50. Xu, H. et al. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br. J. Pharmacol. 153, 1579–1586 (2008).

    Article  CAS  Google Scholar 

  51. Barnes, J. et al. St John's wort (Hypericum perforatum L): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53, 583–600 (2001).

    Article  CAS  Google Scholar 

  52. Du, G. et al. Chinese herbal medicine PC-SPES II induces the apoptosis of androgen-independent prostate carcinoma cell line PC-3 [Chinese]. Zhonghua Nan Ke Xue 13, 563–567 (2007).

    PubMed  Google Scholar 

  53. Small, E. J. et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J. Clin. Oncol. 18, 3595–3603 (2000).

    Article  CAS  Google Scholar 

  54. Guns, E. S. et al. Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol. Can. J. Urol. 9, 1684–1688 (2002).

    CAS  PubMed  Google Scholar 

  55. Oh, W. K. et al. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Clin. Oncol. 22, 3705–3712 (2004).

    Article  CAS  Google Scholar 

  56. American Cancer Society. PC-SPES, PC-HOPE, and PC-CARE [online 19 June 2007], http://www.cancer.org/docroot/ETO/content/ETO_5_3X_PC-SPES.asp?sitearea=ETO (2009).

  57. Bayne, C. W. et al. Serenoa repens (Permixon): a 5-alpha-reductase types I and II inhibitor—new evidence in a coculture model of BPH. Prostate 40, 232–241 (1999).

    Article  CAS  Google Scholar 

  58. Boyle, P. et al. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55, 533–539 (2000).

    Article  CAS  Google Scholar 

  59. Wilt, T., Ishani, A. & MacDonald, R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD001423. doi:10.1002/14651858.CD001423.

  60. Bent, S. et al. Saw palmetto for benign prostatic hyperplasia. N. Engl. J. Med. 354, 557–566 (2006).

    Article  CAS  Google Scholar 

  61. Rao, A. V. et al. Lycopene. Adv. Food Nutr. Res. 51, 99–164 (2006).

    Article  CAS  Google Scholar 

  62. Bertram, J. S. Carotenoids and gene regulation. Nutr. Rev. 57, 182–191 (1999).

    Article  CAS  Google Scholar 

  63. Dahan, K. et al. Lycopene in the prevention of prostate cancer. J. Soc. Integr. Oncol. 6, 29–36 (2008).

    CAS  PubMed  Google Scholar 

  64. Schwarz, S. et al. Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J. Nutr. 138, 49–53 (2008).

    Article  CAS  Google Scholar 

  65. Kucuk, O. et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev. 10, 861–868 (2001).

    CAS  PubMed  Google Scholar 

  66. Jatoi, A. et al. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology 69, 289–294 (2007).

    Article  Google Scholar 

  67. Nagata, Y. et al. Dietary isoflavones may protect against prostate cancer in Japanese men. J. Nutr. 137, 1974–1979 (2007).

    Article  CAS  Google Scholar 

  68. deVere White, R. W. et al. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology 63, 259–263 (2004).

    Article  Google Scholar 

  69. Combs, G. F. Jr et al. An analysis of cancer prevention by selenium. Biofactors 14, 153–159 (2001).

    Article  CAS  Google Scholar 

  70. Diwadkar-Navsariwala, V. et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc. Natl Acad. Sci. USA 103, 8179–8184 (2006).

    Article  CAS  Google Scholar 

  71. Husbeck, B. et al. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action. Mol. Cancer Ther. 5, 2078–2085 (2006).

    Article  CAS  Google Scholar 

  72. Klein, E. A. et al. SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E Cancer Prevention Trial. J. Urol. 166, 1311–1315 (2001).

    Article  CAS  Google Scholar 

  73. Yoshizawa, K. et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl Cancer Inst. 90, 1219–1224 (1998).

    Article  CAS  Google Scholar 

  74. Hartman, T. J. et al. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol. Biomarkers Prev. 7, 335–340 (1998).

    CAS  PubMed  Google Scholar 

  75. Lippman, S. M. et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51 (2009).

    Article  CAS  Google Scholar 

  76. Ishani, A. et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am. J. Med. 109, 654–664 (2000).

    Article  CAS  Google Scholar 

  77. Jepson, R. G. & Craig, J. C. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol. Nutr. Food Res. 51, 738–745 (2007).

    Article  CAS  Google Scholar 

  78. Lawenda, B. D. et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J. Natl Cancer Inst. 100, 773–783 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Integrative Medicine Service, Memorial Sloan–Kettering Cancer Center, New York, NY, USA

    Barrie R. Cassileth, Jyothirmai Gubili & K. Simon Yeung

Authors
  1. Barrie R. Cassileth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jyothirmai Gubili
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Simon Yeung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jyothirmai Gubili.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassileth, B., Gubili, J. & Simon Yeung, K. Integrative medicine: complementary therapies and supplements. Nat Rev Urol 6, 228–233 (2009). https://doi.org/10.1038/nrurol.2009.41

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2009.41

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing